What You Should Know:
– NeuroFlow, a provider of behavioral health technology infrastructure, announced the acquisition of Owl, a measurement-based care (MBC) technology company.
– The strategic acquisition positions NeuroFlow as a leader in behavioral health measurement and engagement, offering a comprehensive suite of solutions for a wider range of healthcare settings.
– While expanding its reach and service offerings, NeuroFlow remains dedicated to customer collaboration and innovation. The combined entity will leverage its expertise to deliver exceptional solutions to existing partners across all 50 states, serving over 17 million individuals on the platform.
Extending Neuroflow Capabilities
This acquisition builds upon NeuroFlow’s previous investment in MBC solutions, including the 2023 acquisition of Capital Solution Design for the U.S. Department of Veterans Affairs. The Owl acquisition extends NeuroFlow’s capabilities directly into behavioral health provider organizations, enabling seamless integration across primary and specialty care settings. This unified platform provides a comprehensive, 360-degree view of a population’s behavioral health risks.
Addressing Systemic Barriers
The combined NeuroFlow-Owl platform tackles a crucial challenge: systemic barriers to behavioral health access. By empowering providers, health plans, and the federal government, the platform works to streamline access to behavioral healthcare. This merger signifies the creation of the largest end-to-end behavioral health measurement solution in the market. It empowers providers across the healthcare spectrum to effectively identify, assess, and coordinate care for patients with behavioral health needs. Furthermore, the combined entity demonstrates a strong commitment to quality monitoring and outcomes tracking, a critical area for innovation within the healthcare system.
A Deeper Understanding of Behavioral Health
The NeuroFlow-Owl platform offers a rich depth of data for a more nuanced understanding of behavioral health. With access to over 400 behavioral health assessments, many available in multiple languages, the platform goes beyond simple clinical assessments. Advanced analytics leverage diverse data sources, including patient-reported information and retrospective health data, to create a more complete picture of each patient’s acuity. NeuroFlow’s artificial intelligence (AI) and natural language processing (NLP) technology plays a vital role, highlighting individuals experiencing suicidal ideation.
Additionally, Owl’s recent impact study with Colorado Access and Aurora Mental Health and Recovery underscores the significant impact of consistent behavioral health measurement. The study demonstrates a clear link between MBC and improved quality of care, while also reducing the total cost of care. NeuroFlow is committed to replicating this success on a national scale.
“Owl is dedicated to improving clinical outcomes in partnership with behavioral health providers and demonstrating meaningful savings for the healthcare ecosystem,” says Eric Meier, Chief Executive Officer at Owl, who will serve as NeuroFlow’s President of Behavioral Health Markets. “We're looking forward to expanding the impact of our technology with NeuroFlow's team and resources. Together, our organizations will provide a truly comprehensive solution that simplifies identification of individuals in need of behavioral health care and guides them through their treatment journey. Ultimately, this merger means we can make the greatest impact on behavioral health outcomes across the healthcare spectrum.”
